Leading the way to safer medication

Azacitidine

Azacytidine

ONUREG VIDAZA

Therapeutic Indications

Azacitidine is indicated for:

at least one of
Acute myeloid leukaemia

Chronic myelomonocytic leukemia, Type II

Myelodysplastic syndromes

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous

Contraindications

Active ingredient Azacitidine is contraindicated in the following cases:

No gender/age discrimination

at least one of
Pregnancy

Lactation

Malignant neoplasm of liver and intrahepatic bile ducts

Secondary malignant neoplasm of liver